Compound screening and synthesis for COVID-19 drug development
Service description
The development of small chemical molecules as drugs requires the use of chemical compound libraries in a high-throughput screening (HTS or HCS) and/or the synthesis of compounds by chemical methods.
In the context of SARS-CoV-2, typical cell models have been used: Vero-E6, HAE, and ex-vivo respiratory tract models... Library screening would be performed with one of those models.
This service is designed for Biotech companies developing SARS-CoV-2 new drugs.
Materials to provide
Details about the project.
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
Typical deliverables
Study following the specifications validated with the Expert.
Get started with your COVID-19 compound library screening project
Please answer the fields below to be contacted by our team of scientists
